Finance

Beta
Lists
060590:KOSDAQ
CTC Bio Inc
3 045,00 KRW
-7,02%
(-230,00) 1D
8-июн., 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 060590...
Open
3 050 KRW
High
3 220 KRW
Low
2 895 KRW
Mkt. cap
73,63 млд
Avg. vol.
144,61 миң
Volume
81,26 миң
P/E ratio
11,92
52-wk high
7 680 KRW
52-wk low
2 895 KRW
EPS
255 KRW
Shares outstanding
24,18 млн
No. of employees
248
Open
3 050 KRW
High
3 220 KRW
Low
2 895 KRW
Mkt. cap
73,63 млд
Avg. vol.
144,61 миң
Volume
81,26 миң
P/E ratio
11,92
52-wk high
7 680 KRW
52-wk low
2 895 KRW
EPS
255 KRW
Shares outstanding
24,18 млн
No. of employees
248
News stories
From sources across the web
About CTC Bio Inc
CEO-
Employees248
Founded1993
Headquarters-
SectorPharmaceutical industry
Websitectcbio.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
30,91 млд
31,80 млд
31,62 млд
34,44 млд
Cost of goods sold
18,22 млд
19,35 млд
18,91 млд
20,10 млд
Cost of revenue
18,22 млд
19,35 млд
18,91 млд
20,10 млд
Research and development expenses
504,89 млн
427,62 млн
482,35 млн
205,61 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,78 млд
10,33 млд
10,29 млд
9,30 млд
Operating expense
10,29 млд
11,00 млд
11,20 млд
9,74 млд
Total operating expenses
28,51 млд
30,35 млд
30,11 млд
29,84 млд
Operating income
2,40 млд
1,45 млд
1,51 млд
4,60 млд
Other non operating income
-2,52 млн
-33,35 млн
-91,96 млн
-55,25 млн
EBT including unusual items
1,51 млд
1,01 млд
-220,58 млн
4,46 млд
EBT excluding unusual items
1,47 млд
943,91 млн
-84,63 млн
4,38 млд
Income tax expense
369,92 млн
656,08 млн
-1,34 млд
955,92 млн
Effective tax rate
24,51%
64,69%
607,65%
21,45%
Other operating expenses
35,80 млн
109,16 млн
92,32 млн
34,12 млн
Net income
1,19 млд
310,40 млн
1,10 млд
3,50 млд
Net profit margin
3,86%
0,98%
3,48%
10,16%
Earnings per share
-
-
-
-
Interest and investment income
73,26 млн
60,95 млн
94,40 млн
73,22 млн
Interest expense
-568,29 млн
-604,79 млн
-569,99 млн
-553,03 млн
Net interest expenses
-495,04 млн
-543,84 млн
-475,58 млн
-479,80 млн
Depreciation and amortization charges
234,44 млн
216,74 млн
200,89 млн
174,52 млн
EBITDA
4,04 млд
3,07 млд
3,11 млд
6,17 млд
Gain or loss from assets sale
-42,83 млн
-94,40 млн
-132,54 млн
-78,68 млн
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer